Financial & Tax Architects’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.91M | Buy |
37,207
+417
| +1% | +$77.4K | 1.68% | 19 |
|
|
2025
Q1 | $7.71M | Sell |
36,790
-292
| -0.8% | -$61.2K | 1.93% | 12 |
|
|
2024
Q4 | $6.59M | Buy |
37,082
+1,662
| +5% | +$295K | 1.68% | 19 |
|
|
2024
Q3 | $6.99M | Sell |
35,420
-2,131
| -6% | -$421K | 1.8% | 15 |
|
|
2024
Q2 | $6.44M | Buy |
37,551
+2,146
| +6% | +$368K | 1.73% | 15 |
|
|
2024
Q1 | $6.45M | Sell |
35,405
-1,736
| -5% | -$316K | 1.77% | 16 |
|
|
2023
Q4 | $5.76M | Sell |
37,141
-168
| -0.5% | -$26K | 1.7% | 18 |
|
|
2023
Q3 | $5.56M | Buy |
37,309
+2,116
| +6% | +$315K | 1.73% | 18 |
|
|
2023
Q2 | $4.74M | Buy |
35,193
+2,835
| +9% | +$382K | 1.46% | 33 |
|
|
2023
Q1 | $5.16M | Buy |
32,358
+1,722
| +6% | +$274K | 1.7% | 18 |
|
|
2022
Q4 | $4.58M | Sell |
30,636
-2,870
| -9% | -$429K | 1.56% | 32 |
|
|
2022
Q3 | $4.5M | Buy |
33,506
+1,786
| +6% | +$240K | 1.69% | 24 |
|
|
2022
Q2 | $4.86M | Buy |
31,720
+2,564
| +9% | +$393K | 1.84% | 15 |
|
|
2022
Q1 | $4.73M | Sell |
29,156
-3,293
| -10% | -$534K | 1.78% | 15 |
|
|
2021
Q4 | $4.39M | Buy |
32,449
+1,770
| +6% | +$240K | 1.79% | 15 |
|
|
2021
Q3 | $3.31M | Buy |
30,679
+1,671
| +6% | +$180K | 1.51% | 30 |
|
|
2021
Q2 | $3.27M | Buy |
29,008
+2,183
| +8% | +$246K | 1.6% | 22 |
|
|
2021
Q1 | $2.9M | Buy |
+26,825
| New | +$2.9M | 1.63% | 20 |
|